Featured Insight
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors' inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life. The firm secured rankings in four distinct categories: Vault Consulting 50 North America Best Boutique Consulting Firms Best Consulting Firms for Women Best Consulting Firms for Formal Training
PRECISIONadvisors New Office Opening in London
The PRECISIONadvisors team is looking forward to welcoming clients and Precision colleagues to their new office opening this week. The client networking event includes a panel discussion on the evolving marketing access environment in the UK featuring Andrew Walker, David Watson and Neil Grubert. Reach out to Richard Macaulay to attend! * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Conference: ISPOR Europe 2023
Precision will be at ISPOR Europe, November 12-15, 2023. * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
How High Can Prices Go? Cell and Gene Therapies
Curious how high prices can go in cell and gene therapies? Read our white paper to learn more about developments in the cell and gene therapy payer world.
China’s NRDL 2022 Update: Spotlight on Rare Disease (Part 3 of 3)
With negotiated prices as much as 95% below launch pricing, marketing rare disease therapies in China is a challenge. PRECISIONadvisors Chloe Wang, Katherine Leong, and Cherry Moldovan discuss alternate access channels. Download the free brief (part 3 of 3).
China NRDL 2022 Update – Spotlight on Oncology (Part 2 of 3)
Recent updates to China’s NRDL have a big impact on oncology therapies. PRECISIONadvisors Chloe Wang, Katherine Leong, and Cherry Moldovan explain what that means for multinationals in this free brief (part 2 of 3).
On Demand: NICE Early Scientific Advice: When, Why, and How!
Have you considered using NICE Scientific Advice (SA) to inform your evidence development, trial design, and/or economic modelling? Are you familiar with the concept of NICE SA, but have no direct experience? Or have you used the process before, but want to learn how to optimise your use of it? Join PRECISIONadvisors on July 26 at 9am EST for a complimentary webinar, as we share our experience with NICE SA in a pragmatic discussion of what it can do for you, and best practices for getting the most from NICE SA.
On Demand: Cell and Gene Therapies – How High Can Prices Go?
This ON24 webinar will discuss how cell and gene therapies can be justifiably priced at different levels. We will explore just how high they can extend and also how we can collectively ensure that patients can access these innovations when they are needed. This discussion will be led by David Carr: Senior Director, Global Pricing and Market Access (PRECISIONadvisors), Richard Macaulay: SVP, Global Pricing and Market Access (PRECISIONadvisors).
On Demand Webinar – Paying for Prevention? Payer Access Challenges and Solutions for Preventative Gene Therapies
Launching a therapy has become increasingly challenging, with only 34% of launches meeting their year-one goals (Evaluate Pharma, McKinsey). In addition, launches have also become more complex, with additional stakeholders to consider as well as the careful navigation of siloed, enterprise-wide functions and dynamic, fragmented data solutions. Not surprisingly, the path to a successful launch can be very narrow.
How High Can Prices Go? Cell and Gene Therapies
Curious how high prices can go in cell and gene therapies? Read our white paper to learn more about developments in the cell and gene therapy payer world.
White Paper: “Preventative” Gene Therapies: Perspectives on Payer Access Challenges and Solutions
Gene therapies offer hope for patients with severe genetic diseases by providing long-term benefits and even cures. However, the challenges of evaluating the long-term benefits of these therapies from a payer perspective are considerable. This white paper by PRECISIONadvisors highlights the shift of gene therapy research into more prevalent diseases, and outlines how manufacturers and payers can co—create evidence requirements and models to optimize launch success and sustainability.
New White Paper: Speeding up Patient Access to Innovation: Strategies to Convert Early European Regulatory Approval Into Optimal Reimbursement
Efforts to facilitate patient access to innovative medicines have taken on new urgency in the pandemic era, sharpening drug developers’ focus on the first step in this process: securing regulatory approval.
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors' inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life. The firm secured rankings in four distinct categories: Vault Consulting 50 North America Best Boutique Consulting Firms Best Consulting Firms for Women Best Consulting Firms for Formal Training
PRECISIONadvisors New Office Opening in London
The PRECISIONadvisors team is looking forward to welcoming clients and Precision colleagues to their new office opening this week. The client networking event includes a panel discussion on the evolving marketing access environment in the UK featuring Andrew Walker, David Watson and Neil Grubert. Reach out to Richard Macaulay to attend! * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
Conference: ISPOR Europe 2023
Precision will be at ISPOR Europe, November 12-15, 2023. * Schedule a meeting with one of our experts * Be sure to attend the two Podium Presentations by Precision's Richard Macaulay on November 14 and 15
On-Demand Webinar — HEOR in 2020: 4 Trends for Market Access
This expert panel tackle head-on some of the hottest topics and trends in health economics and outcomes research today, and what you need to know to be successful in 2020.
AMCP Taps Precision to Lead Value-Based Contracting Workshop
Hosted by the AMCP in collaboration with Precision Xtract, this unique half-day interactive training program will be led by Precision’s Stephen Carter.
Precision is headed to Copenhagen for ISPOR Europe
Precision is excited to be in Copenhagen, November 2nd - 6th! Be sure to catch our scientific presentations taking place throughout the conference and meet our experts.
Evolution of hub services
What began as patient call centers for select complex medicines has expanded to a full suite of support services, ranging from financial assistance to patient education.
World Pharma Pricing & Market Access Congress 2019
Precision will be attending the 2019 World Pharma Pricing & Market Access Congress on March 19th and 20th in Amsterdam!
